Treatment of stage I seminoma: More choices, more dilemmas

Clinical Oncology

Volumn 9, Issue 4, 1997, Pages 210-212

  Mason, M D ^a   Jones, W G ^a  

^a VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; EDITORIAL; PRIORITY JOURNAL; SEMINOMA;

EID: 0030868199     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(97)80002-7     Document Type: Editorial

References (23)

1. Hamilton C Horwich A Easton D Radiotherapy for Stage I seminoma testis: results of treatment and complications Radiother Oncol 6 1986 115 120
2. Schultz HP von der Maase A Rørth M Testicular seminoma in Denmark 1976–1980 Acta Radiol Oncol 23 1984 263 270
3. Horwich A Bell J Mortality and cancer incidence following radiotherapy for seminoma of the testis Radiother Oncol 30 1994 193 198
4. Foss SD Horwich A Stenning SP Optimal field size in the adjuvant treatment of Stage I seminoma — a randomised trial [abstract] Proc ASCO 15 1996 239
5. Glanzmann C Schultz G Lutolf UM Long term morbidity of adjuvant infradiaphragmatic irradiation in patients with testicular cancer and implications for the treatment of Stage I seminoma Radiother Oncol 22 1991 12 18
6. Aass N Foss SD Host H Acute and subacute side effects due to infra-diaphragmatic radiotherapy for testicular cancer: a prospective study Int J Radiat Oncol Biol Phys 22 1992 1057 1064
7. Read G Stenning SP Cullen MH Medical Research Council prospective study of surveillance for Stage I testicular teratoma J Clin Oncol 10 1992 1762 1768
8. Horwich A Alsanjari N A'Hern R Surveillance following orchidectomy for Stage I testicular seminoma Br J Cancer 65 1992 775 788
9. Thomas GM Sturgeon JF Alison M A study of post-orchidectomy surveillance in Stage I testicular seminoma J Urol 142 1989 313 316
10. Gospodarowicz MK Warde PR Catton CN The Princess Margaret Hospital experience with surveillance following orchidectomy for Stage I testicular seminoma [abstract] Proc ASCO 14 1995 244
11. von der Maase H Specht L Jacobsen GK Surveillance following orchidectomy for Stage I seminoma of the testis Eur J Cancer 29A 1993 1931 1934
12. Mason MD Tumour markers Horwich A Testicular cancer — investigation and management 1996 Chapman and Hall London 35 51
13. Mason MD Featherstone T Olliff J Inguinal and iliac lymph node involvement in germ cell tumours of the testis: implications for radiological investigation and for therapy Clin Oncol 3 1991 147 150
14. Khoo VS Rainford K Horwich A The effect of anti-emetics and reduced radiation fields on acute gastrointestinal morbidity of adjuvant radiotherapy in Stage I seminoma of the testis: a randomized pilot study Clin Oncol 9 1997 252 257
15. Zagars GK Babaian RJ Stage I testicular seminoma: rationale for postorchidectomy radiation therapy Int J Radiat Oncol Biol Phys 13 1987 155 162
16. Thomas G Jones W van Oosterom A Consensus statement on the investigation and management of testicular seminoma 1989 Newling DWW Jones WG Prostate and testicular cancer EORTC Genitourinary Group Monograph 7 1980 Wiley-Liss New York 285 294
17. Read J Johnston RJ Short duration radiotherapy in Stage I seminoma of the testis: preliminary results of a prospective study Clin Oncol 5 1993 36 46
18. Schmol HJ Harstrick A Bokenmeyer C Single agent carboplatin for advanced seminoma — a Phase II study Cancer 72 1990 237 243
19. Horwich A Mason M Dearnaley DP Use of carboplatin in germ cell tumours of the testis Semin Oncol 19 1992 72 78
20. Oliver RTD Edmonds PM Ong JYH Pilot studies of 1 and 2 course carboplatin as adjuvant for Stage I seminoma. Should it be tested in a randomised trial against radiotherapy? Int J Radiation Oncology Biol Phys 29 1994 28
21. Diekman KP Kran J Kuster J Adjuvant carbopla-tintherapie beim seminom in klinischen Stadium I Z Urol Poster 1 1994 10 11
22. Kratzik C Kuhrer I Wiltsche C Carboplatin-monotherpie bei Seminomen im Stadium I Acta Chir Aust 25 1993 27 28
23. Mason MD Morrey D Cole A Elimination of microscopic metastases from Stage I and II seminoma with single agent, single cycle carboplatin: a feasible alternative or adjunct to radiotherapy [abstract] Br J Cancer 74 Suppl XXVIII 1996 15